WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005114107) USE OF A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS STEM CELLS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/114107    International Application No.:    PCT/US2005/014176
Publication Date: 01.12.2005 International Filing Date: 25.04.2005
IPC:
G01N 33/569 (2006.01)
Applicants: THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES [US/US]; National Institutes of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852-3804 (US) (For All Designated States Except US).
EPSTEIN, Neal, D. [US/US]; (US) (For US Only).
WINITSKY, Steve, O. [US/US]; (US) (For US Only).
GOPAL, Thiru, V. [US/US]; (US) (For US Only).
HASSANZADEH, Shahin [US/US]; (US) (For US Only)
Inventors: EPSTEIN, Neal, D.; (US).
WINITSKY, Steve, O.; (US).
GOPAL, Thiru, V.; (US).
HASSANZADEH, Shahin; (US)
Agent: CARLSON, Anne; Klarquist Sparkman, LLP, One World Trade Center, Suite 1600, 121 SW Salmon Street, Portland, OR 97204 (US)
Priority Data:
60/565,101 23.04.2004 US
Title (EN) USE OF A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS STEM CELLS
(FR) UTILISATION D'UN ANTICORPS MONOCLONAL SE LIANT SPECIFIQUEMENT A DES CELLULES SOUCHES
Abstract: front page image
(EN)Antibodies are disclosed herein that bind Spoc cells. In one embodiment the antibodies are monoclonal antibodies. The use of antibodies that bind Spoc cells to identify and/or isolate a sub-population of Spoc cells is also disclosed. In one embodiment, a method for treating a neurologic disorder is provided. The method includes administering a sub-population of Spoc cells and/or and neuronal cells differentiated from Spoc cells to treat a neurologic disorder.
(FR)L'invention concerne des anticorps se liant à des cellules Spoc. Dans un mode de réalisation, ces anticorps sont des anticorps monoclonaux. L'invention concerne également l'utilisation d'anticorps se liant à des cellules Spoc pour identifier et/ou isoler une sous-population de cellules Spoc. Un mode de réalisation concerne une méthode de traitement d'un trouble neurologique. Cette méthode consiste à administrer à un patient une sous-population de cellules Spoc et/ou de cellules neuronales différenciées à partir de cellules Spoc afin de traiter un trouble neurologique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)